Henry Schein, Inc. has reached a 52-week high of $90.47, driven by a robust stock increase of 29.1% over the past year. The company's financial growth is underscored by a 9.4% rise in global dental sales and 9.3% growth in North American internal sales, contributing to a total revenue of $12.4 billion—an increase of 23%. Analysts project a long-term growth rate of 11.8%, further enhanced by consistent earnings that have outperformed expectations by an average of 25.5% across the last four quarters.
“Henry Schein, Inc. · reached · new 52-week high · $90.47”
“Henry Schein, Inc. · gained · stock price · 29.1%”
“Henry Schein · noted · global dental sales increase · 9.4%”
“Henry Schein · reported · North American dental internal sales growth · 9.3%”
“Henry Schein · signed · cooperative contract with OMNIA Partners · December 2021”
“Henry Schein · acquired · eAssist Dental Solutions · June 2021”
“Henry Schein · acquired · majority ownership in Jarvis Analytics”
“Henry Schein · beat earnings estimates · in each of the trailing four quarters · average surprise being 25.5%”
“Henry Schein · has an estimated long-term growth rate of · 11.8%”
“Henry Schein · has gained · 29.7% · compared with the industry’s 6.2% growth over the past year”
“Henry Schein · has · long-term growth rate · 11.8%”
“Henry Schein · surpassed estimates · percentage · 25.5%”